TINA.org Supports FTC’s ‘Click to Cancel’ Rule against Industry Challenge
Companies should not be able to trap consumers into subscriptions that they do not want.
StemGenex
A false advertising class-action lawsuit was filed against StemGenex Medical Group in August 2016 and transferred to federal court in November 2016. The complaint alleges that the company misleadingly markets its Stem Cell Treatments will treat diseases – including Alzheimer’s, Parkinson’s, and multiple sclerosis – and 100% of its prior customers are satisfied with its service without a reasonable basis for making such claims. In addition, the complaint alleges that the company omits important information about its Stem Cell Treatments, including the dissatisfaction and complaints of ineffectiveness from customers. (Moorer et al v. StemGenex Medical Group, Inc. et al, Case No. 16-cv-2816, S. D. CA.)
The Latest
Rolling Stone Subscriptions
Getting out may not be as easy as signing up.
Menopause Is the Worst. These Everyday Tools Can Help.
Ellen Lee, The New York Times
Obvi
TINA.org discovers the evidence behind these weight-loss claims is slim.
CATrends: Advertised Apartment Rental Prices
Watch out for hidden fees.